Reyes SG, Castillo RC, Cabrera RA

Idioma: Español
Referencias bibliográficas: 31
Paginas: 619-624
Archivo PDF: 497.54 Kb.

RESUMEN

La enfermedad de Marchiafava-Bignami fue descrita por Marchiafava y Bignami en dos pacientes italianos alcohólicos con crisis convulsivas, coma y muerte. Las características clínicas son variadas; sin embargo, las más frecuentes son demencia, alteración de la atención, dificultad para la marcha y síndrome de desconexión interhemisférica ocasionados por desmielinización del cuerpo calloso. Informamos las características clínicas, radiológicas, histopatológicas y de inmunohistoquímica en tejido obtenido mediante biopsia por estereotaxia y craneotomía, de dos hombres con historia de alcoholismo crónico. El diagnóstico diferencial de las lesiones del cuerpo calloso debe incluir enfermedad de Marchiafava-Bignami , encefalomielitis diseminada aguda, linfoma, glioblastoma multiforme y lesiones infecciosas. Esta es la primera comunicación de pacientes mexicanos con diagnóstico de enfermedad de Marchiafava-Bignami documentado clínica, radiológica e histopatológicamente.

REFERENCIAS (EN ESTE ARTÍCULO)

2. Marchiafava E, Bignami A. Sopra un alterazione del corpo calloso osservata in soggetti alcoolisti. Riv Patol Nerv 1903; 8:544-547.

3. Kosaka K, Aoki M, Kawasaki N, Adachi Y, Konuma I, Iizuka R. A non-alcoholic japanese patient with Wernicke’s encephalopathy and Marchiafava-Bignami disease. Clin Neuropathol 1984; 3:231-6.

4. Leong AS. Marchiafava-Bignami disease in a non-alcoholic indian male. Pathology. 1979; 11:241-9.

5. Canaple S, Rosa A, Mizon JP Marchiafava-Bignami disease. Interhemispheric disconnection, favourable outcome, neurological aspect. Rev Neurol 1992; 148:638–640.

6. Kohler CG, Ances BM, Coleman AR, Ragland JD, Lazarev M,Gur RC Marchiafava-Bignami disease: literature review and case report. Neuropsychiatry Neuropsychol Behav Neurol 2000; 13:67–76.

7. Heinrich A, Runge U, Khaw AV. Clinicoradiologic subtypes of Marchiafava-Bignami disease. J Neurol 2004; 251:1050-9.

8. Friese SA, Bitzer M, Freudenstein D. Classification of acquired lesions of the corpus callosum with MRI. Neuroradiology 2000; 42:795–802.

9. Kuhlmann T, Schröter A, Dechent P. Diagnosis of multifocal B cell lymphoma with preceding demyelinating CNS lesions by single-voxel proton MR spectroscopy. J Neurol Neurosurg Psychiatry 2001; 70:259–262.

10. Navarro JF, Noriega S. Enfermedad de Marchiafava-Bignami. Rev-Neurol. 1999; 28:519-23.

11. Kosaka K, Aoki M, Kawasaki N. A non-alcoholic Japanese patient with Wernicke’s encephalopathy and Marchiafava- Bignami disease. Clin Neuropathol 1984; 3:1-236.

12. Leong ASY. Marchiafava-Bignami disease in a non-alcoholic Indian male. Pathology 1979; 11:241-249.

13. Marjama J, Yoshino MT, Reese Ch. MarchiafavaBignami disease: premorten diagnosis of an acute case utilizing magnetic resonance imaging. J Neuroimaging 1994;4:1069.

14. Heepe P, Nemeth L, Brune F, et al. MarchiafavaBignami disease: a correlative computed tomography and morphological study. Eur Arch Psychiatry Neurol Sci 1988;237:749.

15. Kawamura M, Shiota J, Yagishita T, Hirayama K. Marchiafava-Bignami disease: computed tomographic scan and magnetic resonance imaging. Ann Neurol 1985;18:1034.

16. Yahya C, Meryem Kaya , Semra S. Marchiafava-Bignami disease: cranial MRI and SPECT findings. Clinical Neurology and Neurosurgery 2002; 104:339-341.

17. Chang KH, Cha SH, Han MH. Marchiafava-Bignami disease: serial changes in corpus callosum on MRI. Neuroradiology 1992;34:480-482.

18. Haris I. Sair, Feroze B. Mohamed, Sunil Patel. Diffusion Tensor Imaging and Fiber-Tracking in Marchiafava-Bignami Disease. Journal of Neuroimaging 2006; 16:281-285.

19. Kamaki M, Kawamura M, Moriya H, Hirayama K. Callosal bleeding in a case of MarchiafavaBignami disease. J Neurol Sci 1996;136:869-872.

20. Ruiz-Martinez J, Martinez Perez-Balsa A, Ruibal M, et al. Marchiafava- Bignami disease with widespread extracallosal lesions and favourable course. Neuroradiology 1999; 41:40-43.

21. Shiota J, Nakano I, Kawamura M, Hirayama K. An autopsy case of MarchiafavaBignami disease with peculiar chronological CT changes in the corpus callosum: neuroradiopathological correlations. J Neurol Sci 1996; 136:903-905.

22. Kuhlmann T, Lassmann H, Brück W. Diagnosis of inflammatory demyelination in biopsy specimens: a practical approach. Acta Neuropathol 2008; 115:275-287.

23. Mix E, Olsson T, Correale J, Baig S, Kostulas V, Olsson O, Link H: B cells expressing CD5 are increased in cerebrospinal fluid of patients with multiple sclerosis. Clin Exp Immunol 1990; 79:21-27.

24. Kevin C. O’connor. The Neuroimmunology of Multiple Sclerosis: Possible Roles of T and B Lymphocytes in Immunopathogenesis. J Clin Immunol 2001; 21:81-93.

25. Correale J, Mix E, Olsson T, Kostulas V, Fredrikson S, Hojeberg B, Link H: CD51 B cells and CD4-82 T cells in neuroimmunological diseases. J Neuroimmunol 1991; 32:123-132.

26. Antonio Iglesias, Jan Bauer. T-and b-cell responses to myelin Oligodendrocyte glycoprotein in Experimental autoimmune Encephalomyelitis and Multiple sclerosis. Glia 2001; 36:220-234.

27. Annegrit Gerlach, Eckard Oehm, Jens Wattchow. Use of highdose cortisone in a patient with Marchiafava- Bignami disease. J Neurol 2003;250:758-760.

28. Jun Fukumoto, Takeo Suzuki. Marchiafava-Bignami disease treated by mianserin hydrochloride in short-term evaluated by neuropsychological analysis. Psychogeriatrics 2007;7:25-32.

29. Falangola MF, De Queiroz A. Necrose primaria do corpo caloso (Doença de Marchiafava-Bignami). Arq Neuropsiquiatr 1992;50:507-12.

30. Delangre T, Hannequin D, Clavier E, Denis P, Mihout B, Samson M. Maladie de Marchiafava-Bignami d’evolution favorable. Rev Neurol 1986;142:933-936.

31. Martínez Fernández R, Manzano L, Cabrera F, Arranz A. Enfermedad de Marchiafava-Bignami de evolución clínica favorable. Rev Clin Esp 1992; 190:431-443.